Dreyling, M.; Santoro, A.; Mollica, L.; Leppa, S.; Follows, G. A.; Lenz, G.; Kim, W. S.; Nagler, A.; Panayiotidis, P.; Demeter, J.; Ozcan, M.; Kosinova, M.; Bouabdallah, K.; Morschhauser, F.; Stevens, D. A.; Trevarthen, D.; Giurescu, M.; Kupit, L.; Childs, B. H. and Zinzani, P. L.
(2017):
Copanlisib (COP) in patients with relapsed or refractory indolent B-cell lymphoma: primary results of the pivotal Chronos-1 study.
In: Oncology Research and Treatment, Vol. 40: p. 12
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 2296-5270 |
| Language: | English |
| Item ID: | 52195 |
| Date Deposited: | 14. Jun 2018, 09:49 |
| Last Modified: | 14. Jun 2018, 09:49 |
Actions (login required)
- View Item
